208 related articles for article (PubMed ID: 7436556)
1. Discriminatory indices of response of patients with rheumatoid arthritis treated with D-penicillamine.
Dixon JS; Pickup ME; Lowe JR; Hallett C; Lee MR; Wright V
Ann Rheum Dis; 1980 Aug; 39(4):301-11. PubMed ID: 7436556
[TBL] [Abstract][Full Text] [Related]
2. Combined D-penicillamine and chloroquine treatment of rheumatoid arthritis--a comparative study.
Gibson T; Emery P; Armstrong RD; Crisp AJ; Panayi GS
Br J Rheumatol; 1987 Aug; 26(4):279-84. PubMed ID: 3300834
[TBL] [Abstract][Full Text] [Related]
3. A biochemical comparison of alclofenac and D-penicillamine in rheumatoid arthritis.
Bird HA; Dixon JS; Pickup ME; Lee MR; Wright V
Ann Rheum Dis; 1980 Jun; 39(3):281-4. PubMed ID: 6106453
[TBL] [Abstract][Full Text] [Related]
4. D-penicillamine withdrawal in rheumatoid arthritis.
Ahern MJ; Hall ND; Case K; Maddison PJ
Ann Rheum Dis; 1984 Apr; 43(2):213-7. PubMed ID: 6370151
[TBL] [Abstract][Full Text] [Related]
5. Penicillamine treatment in rheumatoid arthritis. A retrospective study.
Börjesson O; Knutsson LP; Svensson B
Acta Med Scand; 1980; 207(1-2):93-6. PubMed ID: 7368979
[TBL] [Abstract][Full Text] [Related]
6. Clinical and laboratory effects of prolonged therapy with sulfasalazine, gold or penicillamine: the effects of disease duration on treatment response.
Situnayake RD; McConkey B
J Rheumatol; 1990 Oct; 17(10):1268-73. PubMed ID: 1979349
[TBL] [Abstract][Full Text] [Related]
7. Penicillamine in rheumatoid disease: a long-term study.
Day AT; Golding JR; Lee PN; Butterworth AD
Br Med J; 1974 Feb; 1(5900):180-3. PubMed ID: 4590670
[TBL] [Abstract][Full Text] [Related]
8. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
[TBL] [Abstract][Full Text] [Related]
9. Alclofenac and D-penicillamine. Comparative trial in rheumatoid arthritis.
Berry H; Fernandes L; Ford-Hutchinson AW; Evans SJ; Hamilton EB
Ann Rheum Dis; 1978 Feb; 37(1):93-7. PubMed ID: 24426
[TBL] [Abstract][Full Text] [Related]
10. Serum amyloid A protein during the treatment of rheumatoid arthritis with second-line drugs.
Grindulis KA; Scott DL; Robinson MW; Bacon PA; McConkey B
Br J Rheumatol; 1985 May; 24(2):158-63. PubMed ID: 2859902
[TBL] [Abstract][Full Text] [Related]
11. How reliable is ESR as a measure of disease activity in rheumatoid arthritis treated with hydroxychloroquine?
Dixon JS; Greenwood M; Bird HA
Clin Rheumatol; 1988 Jun; 7(2):262-6. PubMed ID: 2901304
[TBL] [Abstract][Full Text] [Related]
12. Serum histidine in rheumatoid arthritis: changes induced by antirheumatic drug therapy.
Pickup ME; Dixon JS; Lowe JR; Wright V
J Rheumatol; 1980; 7(1):71-6. PubMed ID: 7354471
[TBL] [Abstract][Full Text] [Related]
13. A comparison of clinical assessments of disease activity in rheumatoid arthritis.
Rhind VM; Bird HA; Wright V
Ann Rheum Dis; 1980 Apr; 39(2):135-7. PubMed ID: 7387217
[TBL] [Abstract][Full Text] [Related]
14. [Long term treatment of rheumatoid arthritis. Experiences with D-penicillamine in comparison with gold and immunosuppressive drugs (author's transl)].
Warnatz H; Scheiffarth F; Gutmann W
Med Klin; 1975 Sep; 70(38):1509-15. PubMed ID: 810648
[TBL] [Abstract][Full Text] [Related]
15. Progressive joint damage during penicillamine therapy for rheumatoid arthritis.
Scott DL; Greenwood A; Bryans R; Huskisson EC
Rheumatol Int; 1988; 8(3):135-9. PubMed ID: 3175451
[TBL] [Abstract][Full Text] [Related]
16. Maintenance dose of penicillamine in rheumatoid arthritis: a comparison between a standard and a response-related flexible regimen.
Hill HF; Hill AG; Day AT; Brown RM; Golding JR; Lyle WH
Ann Rheum Dis; 1979 Oct; 38(5):429-33. PubMed ID: 518142
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic studies of D-penicillamine in the treatment of rheumatoid arthritis.
Payne RW; Cahill CL
J Okla State Med Assoc; 1969 Oct; 62(10):487-91. PubMed ID: 5406880
[No Abstract] [Full Text] [Related]
18. Degree and extent of response to sulphasalazine or penicillamine therapy for rheumatoid arthritis: results from a routine clinical environment over a two-year period.
Capell HA; Marabani M; Madhok R; Torley H; Hunter JA
Q J Med; 1990 Apr; 75(276):335-44. PubMed ID: 1974723
[TBL] [Abstract][Full Text] [Related]
19. [The concept of basic therapy of chronic polyarthritis with D-penicillamine: clinical experiences over 10 years].
Hohmeister R
Z Rheumatol; 1988; 47 Suppl 1():24-7. PubMed ID: 3145661
[TBL] [Abstract][Full Text] [Related]
20. [The effect of D-penicillamine on the immunological indices of rheumatoid arthritis patients].
Sheĭtanov I
Vutr Boles; 1990; 29(4):59-64. PubMed ID: 2281661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
